Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study).
Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
José Antonio Mata-MarínInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0002-3701-9894
Marisol Apaez-IglesiasInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Ana Luz Cano-DíazInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0001-9659-746X
Juan Pablo Sánchez-NavarroInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0002-8040-4966
Diana Edith Fernández-MadinaveitiaDermatology Department, Hospital General de Zona 1 A "Dr Rodolfo Antonio de Mucha Macías", Instituto Mexicano del Seguro Social, Mexico City 03300, Mexico.
Gustavo Barriga-AnguloLaboratory Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Salma Triana-GonzálezInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0002-4175-025X
Alberto Chaparro-SánchezInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0001-8480-0408
Ericka Nelly Pompa-MeraResearch Unit, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Jesús Enrique Gaytán-MartínezInfectious Diseases Department, Hospital de Infectología "Dr Daniel Méndez Hernández", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.ORCID 0000-0003-1600-1385
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
biologic DMARDsimmune-mediated inflammatory diseaseslatent tuberculosis infectionMexicoQuantiFERON-TB gold plus
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study). · full record | OpenQuestion